Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Point-of-Care Testing, a comprehensive training program that teaches pharmacy technicians to safely perform CLIA-waived tests.

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (418)
    • Blood Glucose Meters (2)
    • Complications (99)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (53)
    • Drug-Induced Hypo/Hyperglycemia (90)
    • Monitoring (73)
    • Natural Medicines/Supplements (8)
    • Prevention (26)
    • Treatment (184)
      • Alpha-Glucosidase Inhibitors (16)
      • Amylin Agonist (8)
      • Bromocriptine (3)
      • Combination Products (14)
      • Gliptins (56)
      • Glitazones (65)
      • GLP-1 (27)
      • Incretin Enhancers/Mimetics (42)
      • Insulin (107)
      • Meglitinides (27)
      • Metformin (82)
      • SGLT2 Inhibitors (43)
      • Sulfonylureas (72)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (9)
  • Hyperglycemia (19)
  • Hypoglycemia (19)
  • Other (15)
  • Prediabetes (2)
  • Resources (123)
  • Thyroid Disorders (41)
136 - 150 of 184 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Sick Day Management of Diabetes March 2013
Chart: Renal Dosing of Gliptins (DPP-4 Inhibitors) December 2012
Article: two new tablet strengths of Januvia (sitagliptin) December 2012
Chart: Safe Use of Single- and Multidose Containers November 2012
Article: About 25% of your patients over age 65 have type 2 diabetes November 2012
Article: handling single-dose vials of injectable drugs properly November 2012
Article: whether it's okay to take certain once-daily diabetes meds (Glumetza, Lantus, etc) twice daily November 2012
Commentary: Glitazones and the Risk of Bladder Cancer October 2012
Article: MORE controversy about using pioglitazone (Actos, etc) for type 2 diabetes October 2012
Commentary: Combining a GLP-1 Agonist and a DPP-4 Inhibitor for Type 2 Diabetes August 2012
Patient Education: Voyager avec ses médicaments August 2012
Article: how to get medications through airport screening August 2012
Article: patients getting combinations of certain diabetes meds...Victoza with Onglyza, Byetta with Januvia, etc August 2012
Guideline: Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada July 2012
Article: more emphasis on the prevention and treatment of type 2 diabetes in CHILDREN July 2012
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved